Stada Enjoys Robust First Half For Generics And Biosimilars

Recently Launched Higher-Strength 100mg/ml Adalimumab Biosimilar

 
• By Dean Rudge
  
Europe from space
Stada remains a major player in the EU • Source: Shutterstock

More from Earnings

More from Business